Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTAGE family member 15 (CTAGE15) is a protein predicted to participate in vesicle trafficking between the endoplasmic reticulum and the Golgi apparatus, supporting protein secretion and cargo loading[1][4]. The protein is predicted to be membrane-associated, localizing to the endoplasmic reticulum or ER exit sites[1]. There is minimal characterization regarding its specific physiological roles, disease associations, or relevance to pharmacology. CTAGE15 has no known therapeutic significance or use as a biomarker. It may be a non-coding pseudogene in some humans, and no drugs target this protein. CTAGE15 should not be confused with CRTAM or nectin/nectin-like family members, which are cell adhesion and immune regulatory proteins[3]. Some sources list CTAGE15 as "Protein Coding", while others refer to it as "pseudogene", indicating it may be non-functional or poorly characterized[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTAGE family member 15 (CTAGE15).